GlassScriptPhysician profile
James I Spak
NPI 1740225416
$1,130.39
in general payments reported to CMS, 2019-2025
11 companies · $350 in 2025
The $350 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2021: $21.35 · 2022: $125 · 2023: $110 · 2024: $327 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $513.40 | 2019-2025 | Orthovisc, Monovisc, Megadyne |
| Stryker Corporation | $242.16 | 2019-2025 | Blueprint Patient Specific Instrumentation, Pangea, Aequalis Ascend Flex |
| Pacira Pharmaceuticals Incorporated | $155.47 | 2022-2025 | Zilretta, Iovera, Exparel |
| Vericel Corporation | $68.77 | 2023-2025 | Maci |
| Pacira Therapeutics, INC. | $38.03 | 2019 | |
| Ermi LLC | $30.74 | 2025 | |
| Orthofix Medical, INC. | $27.32 | 2024 | Accelstim, Physio-Stim |
| Polaris Technology Solutions LLC | $24.69 | 2025 | |
| Innovation Technologies INC | $16.43 | 2025 | Irrisept |
| Sanofi-Aventis U.S. LLC | $13.38 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Spak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.